JP2008526936A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526936A5
JP2008526936A5 JP2007550831A JP2007550831A JP2008526936A5 JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5 JP 2007550831 A JP2007550831 A JP 2007550831A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5
Authority
JP
Japan
Prior art keywords
efficient
developed
series
treatment
discloses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526936A (ja
Filing date
Publication date
Priority claimed from GBGB0500604.4A external-priority patent/GB0500604D0/en
Application filed filed Critical
Publication of JP2008526936A publication Critical patent/JP2008526936A/ja
Publication of JP2008526936A5 publication Critical patent/JP2008526936A5/ja
Pending legal-status Critical Current

Links

JP2007550831A 2005-01-13 2006-01-09 置換インドールの新規製造方法 Pending JP2008526936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process
PCT/GB2006/000060 WO2006075139A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles

Publications (2)

Publication Number Publication Date
JP2008526936A JP2008526936A (ja) 2008-07-24
JP2008526936A5 true JP2008526936A5 (cg-RX-API-DMAC7.html) 2009-02-12

Family

ID=34203986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550831A Pending JP2008526936A (ja) 2005-01-13 2006-01-09 置換インドールの新規製造方法

Country Status (15)

Country Link
US (1) US7781598B2 (cg-RX-API-DMAC7.html)
EP (1) EP1844012A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008526936A (cg-RX-API-DMAC7.html)
KR (1) KR20070104350A (cg-RX-API-DMAC7.html)
CN (1) CN101102999B (cg-RX-API-DMAC7.html)
AU (1) AU2006205697B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0606639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2594391A1 (cg-RX-API-DMAC7.html)
GB (1) GB0500604D0 (cg-RX-API-DMAC7.html)
IL (1) IL183965A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007008348A (cg-RX-API-DMAC7.html)
NO (1) NO20074047L (cg-RX-API-DMAC7.html)
NZ (1) NZ556147A (cg-RX-API-DMAC7.html)
WO (1) WO2006075139A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200705216B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
US7741360B2 (en) 2006-05-26 2010-06-22 Astrazeneca Ab Bi-aryl or aryl-heteroaryl substituted indoles
EP2451780B1 (en) * 2009-07-06 2013-06-19 AstraZeneca AB Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
CN104114169A (zh) 2011-12-16 2014-10-22 阿托佩斯治疗有限公司 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
BR9405737A (pt) 1993-02-24 1995-12-05 Merck & Co Inc Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017256A1 (es) 1997-08-21 2001-09-05 American Home Prod Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden
EP0924209B1 (en) 1997-12-19 2003-05-02 Eli Lilly And Company Hypoglycemic imidazoline compounds
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
WO2000078761A1 (en) 1999-06-23 2000-12-28 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
HUP0203895A3 (en) 1999-12-24 2004-09-28 Aventis Pharma Ltd West Mallin Substituted azaindoles and pharmaceutical compositions containing them and their use
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
US20040242589A1 (en) * 2001-08-07 2004-12-02 Bromidge Steven Mark 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
TWI317634B (en) * 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
PL373410A1 (en) 2002-02-01 2005-08-22 F.Hoffman-La Roche Ag Substituted indoles as alpha-1 agonists
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
EP2423190A1 (en) 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
EP1558614B1 (en) * 2002-10-30 2010-09-01 Merck Frosst Canada Ltd. Pyridopyrrolizine and pyridoindolizine derivatives
EP1569638B1 (en) * 2002-12-03 2007-09-05 F. Hoffmann-La Roche Ag Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
JP2007508363A (ja) 2003-10-14 2007-04-05 オキサジェン リミテッド Crth2アンタゴニスト活性を有する化合物
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
US7741360B2 (en) * 2006-05-26 2010-06-22 Astrazeneca Ab Bi-aryl or aryl-heteroaryl substituted indoles
WO2007140786A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
MX2008015768A (es) 2006-06-28 2009-01-07 Sanofi Aventis Nuevos inhibidores de cxcr2.

Similar Documents

Publication Publication Date Title
CY2016040I1 (el) Επιλογες θεραπειας για τη νοσο του fabry
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
NO343834B1 (no) Farmasøytisk preparat omfattende en omega-karboksylarylsubstituert difenylurea for behandling av cancer
IL233925A0 (en) Pharmaceutical dose for oral administration in the form of tiny particles to prevent incorrect use
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
JP2008501714A5 (cg-RX-API-DMAC7.html)
JP2007525988A5 (cg-RX-API-DMAC7.html)
SI1817282T1 (sl) Derivati fenoksiocetne kisline, uporabni za zdravljenje respiratornih bolezni
JP2007520565A5 (cg-RX-API-DMAC7.html)
GB0410399D0 (en) The treatment of respiratory disease
PL2422786T3 (pl) Nowe kombinacje środków leczniczych do leczenia chorób dróg oddechowych
IL178815A0 (en) The treatment of respiratory disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
JP2008534513A5 (cg-RX-API-DMAC7.html)
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
JP2008519810A5 (cg-RX-API-DMAC7.html)
ME01609B (me) Roflumilast za liječenje pulmonarne hipertenzije
HU0500145D0 (en) Composition for the treatment of oral diseases
CL2007002565A1 (es) Proceso para preparar 2-cloro-5-(3-oxopropil)-n-(triciclo(3.3.1.1)dec-1-ilmetil)-benzamida.
JP2007151536A5 (cg-RX-API-DMAC7.html)
JP2006525341A5 (cg-RX-API-DMAC7.html)
ITRC20050003A1 (it) "copia"
HK1129680A (en) Compounds for the treatment of periodontal disease